<DOC>
	<DOCNO>NCT00439920</DOCNO>
	<brief_summary>The present study aim verify state art illness concern organize centralize sample analysis .</brief_summary>
	<brief_title>GIMEMA LAL 0496 : High-Dose Anthracycline Induction Regimen Treatment Adult ALL .</brief_title>
	<detailed_description>The present trial prospective multicentric GIMEMA study , adult ALL patient extensively analyzed diagnosis multiparametric approach include CC molecular analysis follow gene rearrangement : BCR-ABL , MLL-AF4 , E2A-PBX1 , TEL-AML1 , MLL , p15 p16 deletion order give place carefully characterization genetic lesion occur adult ALL evaluate prognostic significance large cohort patient homogeneously treat . This study require central handle analysis bone marrow ( BM ) peripheral blood sample presentation .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Patients age 1660 Diagnosed previously untreated TALL BALL previously treat ALL patient L3 BALL</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2000</verification_date>
	<keyword>ALL</keyword>
</DOC>